FindTrial
Sign In

Vasoactive Peptides in Portal Pressure

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00163982
Enrollment
Unknown
Registered
2005-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2007-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal Hypertension

Keywords

HVPG > 12 mmHg

Brief summary

This study is looking at the detection of vasoactive peptides in portal hypertension.

Interventions

DRUGNorfloxacin

Sponsors

Bayside Health
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* HVPG \>= 12 mmHg

Countries

Australia

Contacts

Primary ContactWilliam W Kemp, MBBS, FRACP
w.kemp@alfred.org.au92762000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026